IPO
IPO filing, visualized

MED-X, INC.

MXRX · NasdaqS-1/A · Nov 17, 2026Filed

No price range yet · latest SEC filing Nov 17, 2026.

Pinch-zoom for details.

The offering

Shares offered
16.2M
+225K over-allotment option

What the company does

Nevada company, founded in 2014, that develops and sells natural pest-control and consumer wellness products.

Revenue

Quarter

1st 9 months

Operating result

Quarter

1st 9 months

Net result

Quarter

1st 9 months

Things to weigh

  • Loss-making: net loss of $10.0M in 9M 2026.

The numbers

$Q 2025Q 2026Change9M 20259M 2026Change
Revenue496K623K+25.6%1.38M1.65M+19.7%
Operating result(1.69M)(1.97M)−17.0%(5.80M)(9.61M)−65.8%
Net result(1.70M)(2.38M)−40.3%(5.84M)(10.0M)−72.1%
$Q 2025Q 2026Change
Revenue496K623K+25.6%
Operating result(1.69M)(1.97M)−17.0%
Net result(1.70M)(2.38M)−40.3%
$9M 20259M 2026Change
Revenue1.38M1.65M+19.7%
Operating result(5.80M)(9.61M)−65.8%
Net result(5.84M)(10.0M)−72.1%

Values as filed, shortened (K = thousand, M = million, B = billion); losses in parentheses. Change columns compare each period with the same period a year earlier; a bigger loss shows as a negative change. Green is better for the company, red worse; n/m where the sign flips.

Risks

  1. We may be unable to effectively manage future growth
  2. If we are unable to continue as a going concern, our securities will have little or no value
  3. We have a limited operating history, and we may not be able to successfully operate our business or execute our business plan
  4. We may incur significant debt to finance our operations
  5. We compete in an industry that is brand-conscious, so brand name recognition and acceptance of our products are critical to our success
  6. Our brand and image are keys to our business and any inability to maintain a positive brand image could have a material adverse effect on our results…

The filing's own risk-factor headings, shortened.

Strategy

The filing doesn't set out its strategy in a list we could read.

Source: MED-X, INC.'s Form S-1/A, filed with the SEC on Nov 17, 2026 (preliminary prospectus). Figures are as filed; changes are worked out from them. Not investment advice.

10KDecoder10KDecoder.com

10KDecoder (10-K Decoder): decode SEC 10-K filings and IPO prospectuses into dashboards and infographics.